Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2696 stock hub

HKG/2696 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2696is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

40B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2696

In the news

Latest news · HKG/2696

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E27.9

P25 11.7P50 18.9P75 41.4

Trailing P/E43.8

P25 10.7P50 17.9P75 38.5

ROE23.7

P25 -14.7P50 2P75 9.4

ROIC12.2

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2696 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

CNY

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	3,762
Employees Change	247%
Employees Change Percent	7.03
Enterprise value	HKD 43B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100003N76
Last refreshed	2026-05-10
Market cap	HKD 40B
Price	HKD 73.55
Price currency	HKD
Rev Per Employee	1,972,007.14x
Sector	Healthcare
Sic	2836
Symbol	hkg/2696
Website	https://www.henlius.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.3%
EV Earnings	46.76x
EV/EBIT	47.33x
EV/EBITDA	31.24x
EV/FCF	38.9x
EV/Sales	5.8x
FCF yield	2.77%
Forward P/E	27.89x
P/B ratio	9.07x
P/E ratio	43.77x
P/S ratio	5.39x
PE Ratio3 Y	26.95x
PE Ratio5 Y	29.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.26%
EBITDA Margin	17.45%
FCF margin	14.91%
Gross margin	74.77%
Gross Profit	HKD 5.5B
Gross Profit Growth	13.47%
Gross Profit Growth Q	26.96%
Gross Profit Growth3 Y	6.46%
Gross Profit Growth5 Y	9.51%
Net Income	HKD 920.3M
Net Income Growth	0.8%
Net Income Growth Q	0.63%
Net Income Growth Years	0%
Net Income Growth3 Y	6.11%
Pretax Margin	12.18%
Profit Margin	12.41%
Profit Per Employee	HKD 244,641
Profitable Years	3
ROA	4.45
Roa5y	0.62
ROCE	11.01
ROE	23.72
Roe5y	2.52
ROIC	12.17
Roic5y	2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	101.05%
Cagr3y	75.25%
Cagr5y	13.16%
EPS Growth	0.03
EPS Growth Q	-1.15
EPS Growth Years	0
EPS Growth3 Y	5.94
FCF Growth	-7.76%
FCF Growth Q	-57.36%
FCF Growth3 Y	16.47%
FCF Growth5 Y	2.93%
OCF Growth	5.13%
OCF Growth Q	-46.02%
OCF Growth3 Y	10.54%
OCF Growth5 Y	-1.63%
Revenue Growth	16.46x
Revenue Growth Q	29.17x
Revenue Growth Years	7x
Revenue Growth3 Y	5.73x
Revenue Growth5 Y	8.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.58
Assets	HKD 13.8B
Cash	HKD 938.4M
Current Assets	HKD 4B
Current Liabilities	HKD 5.7B
Debt	HKD 4B
Debt EBITDA	HKD 2.91
Debt Equity	HKD 0.91
Debt FCF	HKD 3.62
Equity	HKD 4.4B
Interest Coverage	7.97
Liabilities	HKD 9.3B
Long Term Assets	HKD 9.7B
Long Term Liabilities	HKD 3.7B
Net Cash	HKD -3.1B
Net Cash By Market Cap	HKD -7.67
Net Debt EBITDA	HKD 2.37
Net Debt Equity	HKD 0.7
Net Debt FCF	HKD 2.77
Tangible Book Value	HKD 482.7M
Tangible Book Value Per Share	HKD 0.89
WACC	6.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.71
Inventory Turnover	2.51
Net Working Capital	HKD -57.2M
Quick ratio	0.54
Working Capital	HKD -1.6B
Working Capital Turnover	HKD -3.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	100.96%
200-day SMA	70.18
3Y total return	438.43%
50-day SMA	73.03
50-day SMA vs 200-day SMA	50over200
5Y total return	85.5%
All Time High	92
All Time High Change	-20.05%
All Time High Date	2025-09-09
All Time Low	9.6
All Time Low Change	666.15%
All Time Low Date	2023-10-06
ATR	4.06
Beta	0.52
Beta1y	1.11
Beta2y	0.69
Ch YTD	28.92
High	78.1
High52	92
High52 Date	2025-09-09
High52ch	-20.05%
Low	72.65
Low52	32.75
Low52 Date	2025-05-12
Low52ch	124.58%
Ma50ch	0.72%
Price vs 200-day SMA	4.8%
RSI	44.02
RSI Monthly	69.59
RSI Weekly	53.65
Sharpe ratio	1.35x
Sortino ratio	2.34
Total Return	-0.45%
Tr YTD	28.92
Tr1m	-3.98%
Tr1w	-1.47%
Tr3m	15.28%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 909.3M
Operating Income Growth	-4.54
Operating Income Growth Q	-9.28
Operating Income Growth3 Y	-0.01
Operating margin	12.26

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	137,570,618%
Net Borrowing	10,510,316
Shares Insiders	0.59%
Shares Institutions	17.57%
Shares Out	543,494,853
Shares Qo Q	0.9%
Shares Yo Y	0.45%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 967.8M
Average Volume	812,765.45x
Bv Per Share	8.11
CAPEX	HKD -346.5M
Ch1m	-3.98
Ch1w	-1.47
Ch1y	101
Ch3m	15.28
Ch3y	438.4
Ch5y	85.5
Ch6m	20.38
Change	-5.89%
Change From Open	-5.83
Close	78.15
Days Gap	-0.06
Depreciation Amortization	398,493,787.7
Dollar Volume	96,379,037.4
Earnings Date	2026-05-26
EBIT	HKD 909.3M
EBITDA	HKD 1.3B
EPS	HKD 1.68
F Score	6
FCF	HKD 1.1B
FCF EV Yield	2.57x
FCF Per Share	HKD 2.04
Financing CF	-104,449,483
Fiscal Year End	December
Founded	2,010
Graham Number	17.50961
Graham Upside	-76.19
Income Tax	HKD -17M
Investing CF	-1,331,086,865
Is Primary Listing	1
Last Earnings Date	2026-03-20
Last Report Date	2025-12-31
Lynch Fair Value	HKD 10.26
Lynch Upside	-86.05
Ma150	68.35
Ma150ch	7.61%
Ma20	79.68
Ma20ch	-7.69%
Net CF	8,687,710
Next Earnings Date	2026-05-26
Open	78.1
P FCF Ratio	36.13
P OCF Ratio	27.51
Position In Range	16.51
Ppne	2,972,697,832.8
Price Date	2026-05-08
Price EBITDA	HKD 30.88
Ptbv Ratio	82.81
Relative Volume	1.63x
Revenue	7,418,690,845x
SBC By Revenue	1.87x
Share Based Comp	138,566,019
Tax By Revenue	-0.23x
Tr6m	20.38%
Volume	1,310,388
Z Score	2.19

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2696 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2696 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2696?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.6%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.4%

Negative means the company is buying back shares.

Technical

HKG/2696 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.0

Neutral momentum band

Price vs 200-day MA

+4.8%

50/200-day relationship not available

Beta (5Y)

0.52

Less volatile than the market

Sharpe ratio

1.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2696

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2696 stock rating?

hkg/2696 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2696 analysis?

The full report lives at /stocks/hkg/2696/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2696?

The latest report frames hkg/2696 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2696 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.